Skip to content

Glucagon clinical trials: 79 trials

Page 2 of 2

  1. A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults

    NCT02778113 · Phase 1 · Completed

    Posted results

  2. Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.

    NCT03500484 · Early phase 1 · Terminated

    Posted results

  3. A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

    NCT02806960 · Phase 1 · Terminated

    Posted results

  4. The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA

    NCT03965130 · Phase 1 · Completed

    Posted results

  5. A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes

    NCT04992312 · Phase 1 · Completed

    Posted results

  6. Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

    NCT03139305 · Phase 1 · Active, not recruiting

    Linked paper with results

  7. To Determine Tolerability to Glucagon Infusion in Obese Subjects

    NCT02817659 · Phase 1 · Active, not recruiting

    Linked paper with results

  8. Effects of Glucagon Administration on Energy Expenditure

    NCT02237053 · Phase 1 · Completed

    Linked paper with results

  9. Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

    NCT05214573 · Phase not stated · Completed

    Posted results

  10. DIA_CENTRAL:T2D Treatment Pattern in Central Europe

    NCT03807440 · Phase not stated · Completed

    Posted results

  11. Testing State of the Art Remote Glucose Monitoring at Diabetes Camp

    NCT01680653 · Not applicable · Completed

    Posted results

  12. Pharmacogenetics of Ace Inhibitor-Associated Angioedema

    NCT01413542 · Not applicable · Completed

    Posted results

  13. The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis

    NCT01282164 · Not applicable · Completed

    Posted results

  14. Closed-Loop Glucagon Administration For Hypoglycemia Treatment

    NCT02181127 · Not applicable · Completed

    Posted results

  15. Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

    NCT01161862 · Not applicable · Completed

    Posted results

  16. Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

    NCT03217175 · Not applicable · Terminated

    Posted results

  17. The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas

    NCT02701257 · Not applicable · Terminated

    Posted results

  18. Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver

    NCT01986231 · Not applicable · Completed

    Posted results

  19. Investigating Brown Adipose Tissue Activation in Humans

    NCT01935791 · Not applicable · Completed

    Posted results

  20. Physiologic Response to Glucagon at Varying Insulin Levels

    NCT01483651 · Not applicable · Completed

    Posted results

  21. Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes

    NCT05379686 · Not applicable · Completed

    Posted results

  22. Post Bariatric Closed Loop Glucagon Trial

    NCT02966275 · Not applicable · Completed

    Posted results

  23. Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

    NCT07702461 · Phase not stated · Recruiting

    Linked paper with results

  24. Effects of Glucagon Like Peptide-1 on No-reflow

    NCT02507128 · Not applicable · Status unknown

    Linked paper with results

  25. People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

    NCT07207148 · Phase not stated · Recruiting

    Linked paper with results

  26. The Differential Effects of Diabetes Therapy on Inflammation

    NCT02150707 · Phase not stated · Completed

    Linked paper with results

  27. Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge

    NCT06082973 · Not applicable · Completed

    Linked paper with results

  28. GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

    NCT00716170 · Phase not stated · Completed

    Linked paper with results

  29. Pegvisomant With Glucagon Test to Assess for Adult Growth Hormone Deficiency

    NCT01804413 · Not applicable · Status unknown

    Linked paper with results

How PepBank reports evidence